Acinetobacter baumannii
Clémence Whiteway, Anke Breine, Chantal Philippe, Charles Van der Henst
Vrije Universiteit Brussel Vlaams Instituut voor Biotechnologie VIB-VUB Center for Structural Biology University of Namur
阅读操作
确认中在文库中上传 PDF 后可生成中文音频讲解。
摘要与影响
View Large Image Figure ViewerDownload Hi-res image Download (PPT)KEY FACTS:Isolation of extensively resistant and pan-drug-resistant strains ranked as 'high priority' by the WHO (global priority list of antibiotic-resistant bacteria to guide research, discovery and development of new antibiotics, 2017) and the CDC (antibiotic resistance threats in the USA, 2019).Belongs to the 'ESKAPE' group of most problematic nosocomial pathogens.Resistant to desiccation, disinfectant, oxidative stress, and complement-mediated killing.First described as a fast-growing extracellular bacterium; several strains show a potential for intracellular growth in eukaryotic cells.High genetic diversity; rapidly evolving bacteria, with some isolates competent for natural transformation.Lipooligosaccharide instead of classical lipopolysaccharide, with 14 variants identified so far.At least 128 polysaccharide capsule types identified so far.Presence of several secretion systems (SSs): T1SS, T2SS, and T6SS, but absence of T3SS and T4SS usually found in Gram-negative pathogens.Phenotypic heterogeneity by 'phase variation' within clonal populations, with virulent opaque and capsulated (VIR-O) and avirulent translucent and less capsulated (AV-T) types identified.DISEASE FACTS:Nosocomial, community-acquired, and opportunistic infections.Broad infection sites [skin and soft tissue, urinary tract, digestive and respiratory tracts, blood, central nervous system (meningitis), etc.].Can thrive in hospital settings, with a peculiar virulence based on a ‘persist and resist’ strategy.Infection routes and factors favoring infections: colonization of mechanical devices such as catheters and ventilation equipment, open wounds, major trauma or burns, prolonged hospital stays, and immunocompromisation.Therapeutic dead end because of last-resort antibiotic resistance.TAXONOMY AND CLASSIFICATION:KINGDOM: BacteriaPHYLUM: ProteobacteriaCLASS: GammaproteobacteriaORDER: PseudomonadalesFAMILY: MoraxellaceaeGENUS: AcinetobacterSPECIES: Acinetobacter baumanniiDeclaration of interestsNo interests were declared. KEY FACTS:Isolation of extensively resistant and pan-drug-resistant strains ranked as 'high priority' by the WHO (global priority list of antibiotic-resistant bacteria to guide research, discovery and development of new antibiotics, 2017) and the CDC (antibiotic resistance threats in the USA, 2019).Belongs to the 'ESKAPE' group of most problematic nosocomial pathogens.Resistant to desiccation, disinfectant, oxidative stress, and complement-mediated killing.First described as a fast-growing extracellular bacterium; several strains show a potential for intracellular growth in eukaryotic cells.High genetic diversity; rapidly evolving bacteria, with some isolates competent for natural transformation.Lipooligosaccharide instead of classical lipopolysaccharide, with 14 variants identified so far.At least 128 polysaccharide capsule types identified so far.Presence of several secretion systems (SSs): T1SS, T2SS, and T6SS, but absence of T3SS and T4SS usually found in Gram-negative pathogens.Phenotypic heterogeneity by 'phase variation' within clonal populations, with virulent opaque and capsulated (VIR-O) and avirulent translucent and less capsulated (AV-T) types identified. Isolation of extensively resistant and pan-drug-resistant strains ranked as 'high priority' by the WHO (global priority list of antibiotic-resistant bacteria to guide research, discovery and development of new antibiotics, 2017) and the CDC (antibiotic resistance threats in the USA, 2019). Belongs to the 'ESKAPE' group of most problematic nosocomial pathogens. Resistant to desiccation, disinfectant, oxidative stress, and complement-mediated killing. First described as a fast-growing extracellular bacterium; several strains show a potential for intracellular growth in eukaryotic cells. High genetic diversity; rapidly evolving bacteria, with some isolates competent for natural transformation. Lipooligosaccharide instead of classical lipopolysaccharide, with 14 variants identified so far. At least 128 polysaccharide capsule types identified so far. Presence of several secretion systems (SSs): T1SS, T2SS, and T6SS, but absence of T3SS and T4SS usually found in Gram-negative pathogens. Phenotypic heterogeneity by 'phase variation' within clonal populations, with virulent opaque and capsulated (VIR-O) and avirulent translucent and less capsulated (AV-T) types identified. DISEASE FACTS:Nosocomial, community-acquired, and opportunistic infections.Broad infection sites [skin and soft tissue, urinary tract, digestive and respiratory tracts, blood, central nervous system (meningitis), etc.].Can thrive in hospital settings, with a peculiar virulence based on a ‘persist and resist’ strategy.Infection routes and factors favoring infections: colonization of mechanical devices such as catheters and ventilation equipment, open wounds, major trauma or burns, prolonged hospital stays, and immunocompromisation.Therapeutic dead end because of last-resort antibiotic resistance. Nosocomial, community-acquired, and opportunistic infections. Broad infection sites [skin and soft tissue, urinary tract, digestive and respiratory tracts, blood, central nervous system (meningitis), etc.]. Can thrive in hospital settings, with a peculiar virulence based on a ‘persist and resist’ strategy. Infection routes and factors favoring infections: colonization of mechanical devices such as catheters and ventilation equipment, open wounds, major trauma or burns, prolonged hospital stays, and immunocompromisation. Therapeutic dead end because of last-resort antibiotic resistance. TAXONOMY AND CLASSIFICATION:KINGDOM: BacteriaPHYLUM: ProteobacteriaCLASS: GammaproteobacteriaORDER: PseudomonadalesFAMILY: MoraxellaceaeGENUS: AcinetobacterSPECIES: Acinetobacter baumannii KINGDOM: Bacteria PHYLUM: Proteobacteria CLASS: Gammaproteobacteria ORDER: Pseudomonadales FAMILY: Moraxellaceae GENUS: Acinetobacter SPECIES: Acinetobacter baumannii Declaration of interestsNo interests were declared. No interests were declared.
逐年被引趋势
关键指标
同类平均 = 1
同领域 · 同年份 · 同类型
Google Scholar 与 OpenAlex 的被引统计范围不同,数值存在差异属正常。
AI 辅助阅读
依据:摘要
可就本文提问;依据不足时会说明。
学术脉络
学科主题
生物医学Antibiotic Resistance in Bacteria
Infections and bacterial resistance · Bacterial biofilms and quorum sensing